The Tomorrow’s Quants series explores the skills needed by new quant recruits, drawing on a survey of 39 employers, and six ...
Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
Rural Americans face significant barriers to accessing adequate primary care; tailored federal and state programs can help ...
Astreya recently served as a Prize Partner at A2HACKFEST 2K25 in Bengaluru, underscoring its commitment to investing in the ...
With Moore going 27/30 on the night there were few failed passing plays to illustrate. The most common failures were screen ...
Agenda-setting capability emerges when research institutions collectively shape policy discussions, investment priorities, ...
Jefferies London Healthcare Conference 2025 November 18, 2025 3:30 AM ESTCompany ParticipantsWilliam Lewis - President, CEO ...
Chronic obstructive pulmonary disease (COPD) is straining Europe’s healthcare budgets, primarily through preventable ...
Acurx Pharmaceuticals, Inc. (Nasdaq ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Determining the least expensive path for a new subway line underneath a metropolis like New York City is a colossal planning challenge—involving thousands of potential routes through hundreds of city ...
This study provides valuable data on the role of Hsd17b7, a gene involved in cholesterol biosynthesis, as a potential regulator of mechanosensory hair cell function. The authors used both zebrafish ...
Kinesin-1 is a dynamic heterotetrameric assembly of two heavy and two light chains (KHC and KLC) that mediates microtubule-based intracellular transport of many different cargoes. The complex adopts a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback